Ürün
Hizmetler
İş İlanları Haberler Paketler
Girişim, Kişi, İlan, Kurum ara
Search
TR Arrow Down
WeGlo Logo

WeGlo

Lübnan

Sektörü Sağlık
Çalışan Sayısı 4-10
Şirketleşti mi? Hayır
Kuruluş Tarihi 1 Ağustos 2016

Açıklama

https://weglo.net/

Yatırımlar

Rekabet Avantajı

Near-term targeting: We will target the European market ( due to the lower restrictions in terms approval "CE Mark), meanwhile, we will be working on getting the FDA Approval to enter the US Market. Our basic targeting are caregivers who take care of people with diabetes above 65years old (Due to new technologies, life expectancy has increased by 1 year in this demographic segment) Diabetics ranging from 25 to 55 years in emerging and low-income countries, these countries are driving the rise in health care expenditures through 2020 as well as the expansion of services in developed countries

Detaylı Bilgiler

Gelir Modeli Açıklaması

Our technology challenges the status quo of existing measurement practices and advances innovative research in noninvasive glucose sensing. As research moves toward an artificial pancreas, there is an overwhelming need for better glucose sensing systems that make it easier to check your blood sugar. This means developing a system with: No lags Greater accuracy Long-life sensor Better ease of use Decreased cost Our technology overcomes these existing challenges. We are developing this device as a unique opportunity to make a positive, direct impact on the lives of people with diabetes.